Our in vivo data further suggest that intraovarian injection of BM-hMSC stimulates BMP2 gene expression and suppresses androgen-synthesizing gene CYP17A1 expression in the PCOS mouse ovary. This evidence concerns the gene CYP17A1 and polycystic ovary syndrome.